Insomnia: Mechanisms, Causes, and Evidence-Based Strategies for Sleep Onset and Maintenance Disorders

Insomnia is a disorder characterized by difficulty initiating sleep, difficulty maintaining sleep, or early-morning awakenings, despite adequate opportunity for sleep, accompanied by daytime impairment (e.g., fatigue, impaired concentration, mood disturbance, and reduced functioning). Clinically, insomnia is not simply “sleepiness failure”; it reflects dysregulation of sleep-wake physiology and heightened arousal that persists across nights.

A central reason many people struggle with insomnia is an imbalance between hyperarousal systems (cognitive, emotional, and neurobiological) and the normal processes that promote sleep. The two-process model of sleep regulation helps explain this: (1) circadian drive aligns sleep with the biological night, and (2) homeostatic sleep pressure builds with wakefulness. In insomnia, even when sleep pressure is present, arousal systems can prevent sleep from consolidating. Hyperarousal involves increased sympathetic activity, altered stress-hormone signaling, and disrupted autonomic regulation. In many patients, the brain’s threat-detection and anticipatory networks remain active at bedtime, amplifying vigilance and reducing the likelihood of sleep onset.

Cognitive factors play a major mechanistic role. Many individuals develop maladaptive sleep-related beliefs such as “I must sleep tonight to function tomorrow” or catastrophic worry about the consequences of poor sleep. This produces conditioned arousal: the bed and bedroom become cues that predict wakefulness or performance pressure. Over time, people may engage in safety behaviors (checking the clock, repeated attempts to force sleep, adjusting environment repeatedly), which further strengthen the association between bedtime and wakefulness. Cognitive arousal can include rumination, threat appraisal, and attentional bias toward bodily sensations (e.g., noticing heartbeat, breathing, or restlessness), all of which can increase physiological activation.

Physiologically, insomnia is associated with abnormalities in sleep architecture and arousal thresholds. Patients often experience lighter non-rapid eye movement (NREM) sleep, increased transitions between sleep stages, and more frequent micro-arousals. Even if total sleep time seems adequate, sleep continuity may be poor, generating non-restorative sleep and persistent daytime symptoms. Neurotransmitter systems also matter: inadequate inhibitory signaling (e.g., reduced effectiveness of gamma-aminobutyric acid pathways relative to arousal inputs) and altered orexin/hypocretin dynamics may contribute to instability of sleep maintenance in susceptible individuals.

Insomnia can be primary or secondary. Secondary insomnia commonly accompanies comorbid psychiatric conditions (anxiety disorders, major depressive disorder, post-traumatic stress disorder), neurologic and medical diseases (chronic pain, gastroesophageal reflux, restless legs syndrome, asthma), and substance or medication effects (caffeine, nicotine, alcohol rebound, corticosteroids, some antidepressants, and stimulants). Circadian rhythm disturbances—such as delayed sleep-wake phase disorder or shift-work sleep disorder—can mimic insomnia by misaligning sleep timing with endogenous rhythms. Additionally, environmental and behavioral drivers (irregular schedules, prolonged time in bed, daytime napping, inadequate light exposure, and sedentary behavior) worsen both circadian alignment and homeostatic pressure regulation.

The insomnia persistence is often explained by a vicious cycle model: (1) pre-sleep worry and arousal; (2) delayed sleep onset or fragmented sleep; (3) fear of consequences and increased effort to sleep; (4) daytime fatigue that increases evening napping or earlier bedtime, leading to further circadian and homeostatic disruption; and (5) reinforcement of conditioned arousal in the sleep context. This model underscores why “trying harder to sleep” can paradoxically worsen outcomes.

Evidence-based treatment targets the maintaining mechanisms rather than only symptom suppression. Cognitive behavioral therapy for insomnia (CBT-I) is first-line and includes stimulus control (associating bed with sleep), sleep restriction therapy (temporarily consolidating sleep to increase sleep drive), cognitive restructuring (reducing catastrophic beliefs and performance pressure), and relaxation or mindfulness-based approaches to lower arousal. When appropriate, pharmacotherapy may be used short-term or as adjunctive treatment (e.g., certain hypnotics), but it does not replace CBT-I’s durable cognitive and behavioral effects. For insomnia secondary to comorbidities, treating the underlying condition (pain management, restless legs evaluation, reflux control, or optimizing psychiatric care) is often necessary for sustained improvement.

In practice, clinicians assess insomnia duration, sleep schedule, sleep opportunity, comorbid conditions, medications, caffeine/alcohol use, and behavioral patterns in bed. Sleep diaries and actigraphy can help identify circadian misalignment and quantify sleep timing. Reducing cognitive arousal before bed, stabilizing the sleep-wake schedule, limiting time awake in bed, and addressing perpetuating beliefs form the core of care.

In summary, the main reason people struggle with insomnia is often not a single cause but an interaction between hyperarousal physiology, maladaptive sleep cognition, and conditioned behavioral patterns that prevent sleep consolidation. Understanding these maintaining mechanisms clarifies why CBT-I is effective and why personalized assessment is essential to address secondary contributors.

Source: [@Bis_ade_]